Artivion Inc   (AORT)
Other Ticker:  
Price: $19.6100 $-0.51 -2.535%
Day's High: $20.39 Week Perf: 0.2 %
Day's Low: $ 19.60 30 Day Perf: 16.52 %
Volume (M): 228 52 Wk High: $ 20.49
Volume (M$): $ 4,461 52 Wk Avg: $15.57
Open: $20.18 52 Wk Low: $11.44

 Market Capitalization (Millions $) 802
 Shares Outstanding (Millions) 41
 Employees 1
 Revenues (TTM) (Millions $) 353
 Net Income (TTM) (Millions $) -31
 Cash Flow (TTM) (Millions $) 20
 Capital Exp. (TTM) (Millions $) 7

Artivion Inc
Artivion Inc is a technology company based in San Francisco, California, that focuses on providing solutions for the healthcare industry using emerging technologies such as artificial intelligence and machine learning. The company was founded in 2018 by a team of former Google employees and healthcare professionals.

Artivion's mission is to bring revolutionary advancements in healthcare by leveraging the power of data and artificial intelligence. The company is dedicated to creating innovative and cost-effective healthcare solutions that improve patient outcomes and drive efficiency in healthcare operations.

Artivion's flagship product is the Clinical Intent Engine (CIE), an AI-driven platform that helps healthcare professionals to quickly and accurately analyze medical records, identify clinical insights, and make informed decisions based on the available data. CIE is designed to integrate with existing electronic health records (EHR) systems and helps to identify patient risk factors, understand treatment options, and monitor outcomes.

In addition to the CIE platform, Artivion offers consulting services to healthcare organizations to help them optimize their workflows and improve their operations. The company also collaborates with leading academic institutions and healthcare organizations to develop cutting-edge solutions for the industry.

One of Artivion's key strengths is its team of experts in healthcare and artificial intelligence. The company's leadership includes experienced healthcare professionals, including physicians and clinical researchers, as well as experts in AI and machine learning. This combination of knowledge and expertise allows Artivion to develop solutions that are both clinically relevant and technologically advanced.

Overall, Artivion's focus on healthcare, advanced technology, and data-driven solutions positions the company well for growth and impact in the industry.

   Company Address: 1655 Roberts Boulevard N.W. Kennesaw 30144 GA
   Company Phone Number: 419-3355   Stock Exchange / Ticker: NYSE AORT


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Artivion Inc

Artivion Inc Hit with $3.38 Million Tax Charge: What This Means for the Company's Future

Financial News Report: Artivion Inc Reports Improved EPS and Revenue Growth in the Fourth Quarter of 2023
Artivion Inc, a leading company in the Medical Equipment & Supplies industry, has released its financial report for the fourth quarter of 2023, covering the period from October to December 31. The company has shown significant improvement in its earnings per share (EPS) and revenue compared to the previous year.
In terms of EPS, Artivion Inc experienced a loss of $0.10 per share, which is an increase from a loss of $0.05 per share in the same period last year. However, it is worth noting that the company has shown improvement from the previous financial reporting period, with EPS improving from a loss of $0.24 per share.

Artivion Inc

Despite Strong Revenue Growth, Artivion Inc Falls Short of Profitability Goals in 2023 Q3

The stock market can be a rollercoaster ride, with ups and downs that can make even the most seasoned investor nervous. However, when we look deeper into the numbers and trends, we can find some silver linings that may bring a smile to investors' faces.
Artivion Inc, a medical equipment and supplies company, recently reported a 13.577% increase in revenue in the third quarter of 2023 compared to the same period last year. This is indeed a positive sign, showcasing the company's growth and ability to generate more income. Even though the company experienced a loss of $-0.24 per share, it's important to remember that revenue growth is a key factor in long-term success.

Artivion Inc

Artivion Inc Surprises with Reduced Losses and Revenue Spike in Q2 2023 Fiscal Interval

Artivion Inc, a prominent player in the market, exhibited favorable financial performance during the fiscal interval of April to June 2023. This article will delve into the various aspects of the company's performance, highlighting notable facts and figures from the period.
Improved Earnings Per Share (EPS)
Artivion Inc managed to diminish its loss per share, as they lowered it to $-0.08 per share compared to $-0.11 in the same period last year. Furthermore, the company's EPS also saw an improvement from $-0.33 per share in the previous reporting period.

Artivion Inc

AORT Demonstrates Exemplary Resilience During Artivion Inc's Challenging First Quarter of 2023

In the first financial quarter of 2023, Artivion Inc, a renowned corporation, has experienced mixed results. The company has reported a deficit per share of $-0.33 compared to $-0.08 in the last year, signifying an increase of $0.25 per share. Furthermore, the company experienced a decline in earnings per share, decreasing from $0.05 in the previous quarter.
However, Artivion Inc witnessed growth in its revenue, which advanced by 7.791 % to reach $83.23 million, as compared to $77.21 million during the same quarter of the previous year. The sequential revenue growth rose by 4.825 % to reach $79.40 million. These figures indicate that Artivion Inc was successful in increasing its revenue and expanding its customer base.
Despite the growth in revenue, the corporation realized a net deficit of $-13.532 million in the first financial quarter of 2023, which is higher than the deficit of $-3.389 million reported during the same period last year. These results indicate that the cost of operation might have increased compared to the revenue generated.


Artivion Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Artivion Inc does not provide revenue guidance.

Earnings Outlook
Artivion Inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com